Only two-thirds of donations to Ebola crisis have reached affected countries

February 03, 2015

As of Dec. 31, 2014, pledges to the Ebola outbreak reached at least $2.89 billion, yet only around two-thirds ($1.9 billion) has actually reached affected countries, finds a report published by The BMJ this week.

"These delays in disbursements of funding "may have contributed to spread of the virus and could have increased the financial needs," argues author Karen Grépin, Assistant Professor of global health policy at New York University.

Using international donations captured by the UN Office for the Coordination of Humanitarian Affairs' (OCHA) financial tracking system, she examined the level and speed of pledges made to the Ebola epidemic and how they aligned with evolving estimates of funds required to bring the epidemic under control.

On 23 March 2014, Guinea's Ministry of Health notified the World Health Organization (WHO) of a "rapidly evolving outbreak" of Ebola virus disease in the south eastern part of its country. Within a week of the notification, WHO sent an initial donation of protective equipment and other medical supplies to Guinea.

However, the first major appeal to the international community for funding did not happen until August, when WHO, along with the presidents of Liberia, Sierra Leone, and Guinea, called on international donors to provide $71m to support the control of the outbreak.

On 16 September 2014, roughly six months after the start of the epidemic, the UN estimated that nearly $1bn in humanitarian assistance. By mid-November, the official request for funding was estimated at $1.5bn.

"Clearly, international leaders have found it challenging to estimate the financial requirements to tackle this rapidly spreading outbreak," says Grépin. "The problem has not been the generosity of donors but that the resources have not been deployed rapidly enough."

The data do not allow the speed of disbursements to be compared with that for other humanitarian crises, she explains, "but they do suggest that we need a mechanism to enable more rapid disbursement of funds to fight public health threats such as Ebola, such as a dedicated fund that could be rapidly deployed for any emergency."

"Monitoring and tracking donor responses to the epidemic, and how the money was spent, is important to improve our response to future public health threats," she adds. "Learning from this experience will help us to understand what worked and what did not in this epidemic and will also help us better assess funding needs in the future."
-end-


BMJ

Related Ebola Articles from Brightsurf:

Targeting the shell of the Ebola virus
As the world grapples with COVID-19, the Ebola virus is again raging.

Why doesn't Ebola cause disease in bats, as it does in people?
A new study by researchers from The University of Texas Medical Branch at Galveston uncovered new information on why the Ebola virus can live within bats without causing them harm, while the same virus wreaks deadly havoc to people.

Ebola transmission risks would be taken more seriously with ground-up interventions
A study led by the University of Kent's Durrell Institute of Conservation and Ecology (DICE) has found significant differences in disease risk perception and channels of information about Ebola virus disease (EVD) in rural areas and urban centres of Guinea, West Africa.

US inroads to better Ebola vaccine
As the world focuses on finding a COVID-19 vaccine, research continues on other potentially catastrophic pandemic diseases, including Ebola and Marburg viruses.

Ebola antibodies at work
Scientists in Israel and Germany show, on the molecular level, how an experimental vaccine offers long-term protection against the disease.

Half of Ebola outbreaks undetected
An estimated half of Ebola virus disease outbreaks have gone undetected since it was discovered in 1976, according to research published in PLOS Neglected Tropical Diseases.

Protecting those on the frontline from Ebola
Online training developed at the Medical University of South Carolina (MUSC) increased the knowledge of health care workers about effective prevention of Ebola up to 19 percent and reduced critical errors to 2.3 percent in a small MUSC cohort.

Another piece of Ebola virus puzzle identified
A team of researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts.

How the human immune system protects against Ebola
'The current approach for treatment of filovirus infections with antibody cocktails tested in animal models utilizes the principle of targeting of non-overlapping epitopes.

How to slow down Ebola
The phylogenetic tree of the 2013-2016 Ebola epidemic doesn't just tell us how the Ebola virus was able to evolve: it also reveals which events and preventive measures accelerated or slowed down its spread.

Read More: Ebola News and Ebola Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.